Rising Lifestyle Related Health Issues and Obesity Drives the Growth of the Global High BP/Hypertension Drugs and Device Market| Market Opportunities and Forecast, 2018-2023 | Major Companies: Eli Lilly and Co., Pfizer, Inc., Bayer AG, Novartis International AG, Merck KGaA and Sanofi S.A.
Orion Market Research (OMR) recently published a market research report on the global high BP/hypertension drugs and device market. According to OMR analysis, the global high BP/hypertension drugs and device market is estimated to grow at a significant CAGR during the forecast period (2018-2023). The market is growing significantly due to various factors, such as increasing incidences of high BP/hypertension and government-funded programs and initiatives. Rising lifestyle-related health issues and obesity among people due to the consumption of fast foods and unhealthy food is also driving the growth of the market.
A full report of global high BP/hypertension drugs and device market is available at: https://www.omrglobal.com/industry-reports/hypertension-drugs-monitoring-device-market/
Furthermore, the global high BP/hypertension drugs and device market is segmented on the basis of drugs, monitoring devices, and end-user. The report provides detailed & insightful chapters which include market overview, key findings, strategic recommendations, market estimations, market determinants, key company analysis, market insights, company profiling, market segmentation, geographical analysis, analyst insights and predictive analysis of the market.
Visit here to know more about High BP/Hypertension Drugs and Device Market Size.
Market Segmentation
1. Global High BP/Hypertension by Drugs

• Pulmonary Hypertension Drugs
• Systemic Hypertension Drugs

2. Global High BP/Hypertension by Monitoring Devices
• Aneroid Sphygmomanometers
• Mercury Sphygmomanometer
• Digital Devices
• Ambulatory BP Monitors

3. Global High BP/Hypertension by End User
• Hospitals and Clinics
• Homecare

Region Covered

• North America (US and Canada)
• Europe (United Kingdom, Germany, France, Spain, and Italy)
• Asia-Pacific (China, India, South Korea, and Japan)
• Rest of the World (Middle East & Africa and Latin America)

Company Profiled

• Actelion Pharmaceuticals Ltd.
• Alvogen, Inc.
• American Diagnostic Corp.
• Bayer AG
• Boehringer Ingelheim Gmbh
• Briggs Healthcare, Inc.
• Conatus Pharmaceuticals, Inc.
• Contec Medical Systems Co., Ltd.


Request a free sample of our report on High BP/Hypertension Drugs and Device Market: https://www.omrglobal.com/request-sample/?id=18268


The key questions answered in the High BP/Hypertension Drugs and Device Market study:
• To analyze the High BP/Hypertension Drugs and Device Market size (values and volume) by Drugs, Monitoring Devices, End User with historical data of 2017 and 2018 and forecast to 2023.
• To study the key factors influencing the growth of the market.
• Focuses on the key leaders to define and analyze the sales volume, value, share, competitive landscapes, SWOT analysis, and development plans.
• To analyze the High BP/Hypertension Drugs and Device Market growth, global trends, future prospectus and contribution to the market.

For related reports
• Point-of-Care Diagnostics Market
• Surgical Microscope Market
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +1 646-755-7667, +91 780-304-0404